Surgical Resection and Pazopanib Treatment for Recurrent Cardiac Angiosarcoma
Cardiac sarcoma treatment is challenging for surgeons because of frequent tumor recurrence and poor prognosis. In addition, optimal management of recurrences is not well established. The multi-targeted tyrosine kinase inhibitor, pazopanib, was recently approved for soft-tissue sarcoma. Herein, we pr...
Shranjeno v:
Main Authors: | , , , , , , , |
---|---|
Format: | Knjiga |
Izdano: |
SAGE Publishing,
2019-02-01T00:00:00Z.
|
Teme: | |
Online dostop: | Connect to this object online. |
Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
Signatura: |
A1234.567 |
---|---|
Kopija 1 | Prosto |